Articles Alert

The Scientist has asked a group of experts to periodically comment upon recent articles that they have found noteworthy. Their selections, presented here in every issue, are neither endorsements of content nor the result of systematic searching. Rather, they are personal choices of articles they believe the scientific community as a whole may also find interesting. Reprint. of any artieles cited here may be ordered through The Genuine Article, 5501 Market St., Philadelphia, Pa. 19104, or by tel

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BY FRANK A. WILCZEK
Institute for Theoretical Physics
University of California, Santa Barbara
Santa Barbara, Calif.

" The theory of supernovae has reached a new level of sophistication and conviction, post Supernova 1987a. This is reflected in a collection of authoritative articles

G. Brown, editor, Physics Reports, 163(1), 1-204, 1988.

"Three recent developments in the continuing quest to identify the ‘dark matter’ making up most of the mass of the Universe are noteworthy:

First, a reported anomalous excess of antiprotons, interpreted as possible evidence in heavy neutrino or photino annihilation, has not been confirmed.

S.P. Ablen, S. Barwick, J.J. Beatty, C.R Bower, G. Gerbier, et al., “New limit on the low-energy antiproton/proton ratio in the galactic cosmic radiation,” Physical Review Letters, 61(2), 145-8, 11 July 1988.

Second. improved experimental limits on possible deposit of energy by scattering of background heavy particles in matter have been reported.

D.O. Caldwell, R.M. Eisberg, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies